About this trial
For children and adolescents with diabetes, the pathological process of atherosclerotic cardiovascular disease(ASCVD) can exist in early childhood and progress rapidly to subclinical ASCVD. This study intends to explore the models for the prediction of ASCVD risk in childhood and teen-age onset diabetes with different types.
Eligibility criteria
Qualifiers
Diagnosis of type 1 diabetes or type 2 diabetes
Age of onset: <18y
Enrollment age: ≥18y
Gender: male or female
Disqualifiers
Specific types of diabetes
Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes
Pregnancy or lactation
Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously
Trial design
Treatments tested in this trial
- Not listed